Monitoring, Evaluation, and Reporting Indicator Reference ...

1 UNCLASSIFIED 1 MER (Version ) September 2020 monitoring , evaluation , and Reporting Indicator Reference Guide 2 UNCLASSIFIED THIS PAGE IS INTENTIONALLY LEFT BLANK. OVERVIEW 3 UNCLASSIFIED Table of Contents Table of Contents .. 3 Tables & Figures .. 5 Abbreviations .. 6 Acknowledgments .. 8 Overview .. 9 Person-Centered monitoring .. 10 MER Reporting Requirements .. 12 Disaggregated 12 Location: .. 12 Age:.. 12 Sex: .. 12 Key Populations: .. 13 Priority Populations: .. 13 Types of PEPFAR Support: .. 13 Disaggregation Types: .. 13 Required Disaggregations: .. 13 Conditional Disaggregations.

2 13 Optional Disaggregations: .. 13 PEPFAR Support to Communities and Sites .. 13 DSD: .. 14 TA-SDI: .. 14 Support in Centrally Supported Areas: .. 14 Age Disaggregations: .. 15 Host Country National Program .. 15 Host Country Targets .. 16 Host Country Results .. 16 Reporting MER Results in DATIM .. 16 Routine Data Cleaning & Completeness Checks .. 17 Data Entry and Review Process Overview .. 18 Implementing Partner Review Process .. 18 Agency Review Process .. 18 Interagency Review Process .. 18 Data Review Completeness Tools .. 19 MER Data Cleaning and Completeness Review Favorites .. 19 Auto-Population of HTS_TST Modalities.

3 20 Auto-Sum Numerators and Denominators: .. 21 MER Indicator Narratives .. 21 Guiding Narrative Questions .. 21 Implementing Mechanism (IM) Indicator Narratives .. 21 USG Technical Area Indicator Narratives .. 21 Host Country Indicator Targets & Results Narratives .. 22 Justification Narrative .. 22 Source Narrative .. 22 Initiative-Specific Narratives .. 22 Calculated Indicators .. 22 Data Quality .. 23 Standardized Health Data Exchanges & Surveillance Systems .. 24 Commitment to data transparency .. 24 Key Updates and Changes: MER to MER .. 25 Indicator Trainings: .. 25 New Indicators.

4 25 4 UNCLASSIFIED New Disaggregations: .. 25 Changes in Reporting Frequency: .. 25 Modifications to Existing Disaggregations .. 25 Retired Indicators .. 25 Indicator Definition Clarifications .. 26 Language Changes .. 26 Central Support: .. 26 How to read a PEPFAR Indicator Reference sheet .. 32 PREVENTION & SUPPORT INDICATORS .. 33 AGYW_PREV .. 34 FPINT_SITE .. 44 GEND_GBV .. 48 KP_MAT .. 51 KP_PREV .. 53 OVC_SERV .. 57 PP_PREV .. 65 PrEP_CURR .. 70 PrEP_NEW .. 73 TB_PREV .. 75 VMMC_CIRC .. 79 TESTING INDICATORS .. 81 CXCA_SCRN (including CXCA_SCRN_POS) .. 82 HTS_INDEX .. 86 HTS_RECENT .. 93 HTS_SELF.

5 100 HTS_TST (including HTS_TST_POS) .. 104 OVC_HIVSTAT .. 113 PMTCT_EID .. 119 PMTCT_FO .. 122 PMTCT_HEI_POS .. 125 PMTCT_STAT (including PMTCT_STAT_POS) .. 129 TB_STAT (including TB_STAT_POS) .. 132 TREATMENT INDICATORS .. 134 CXCA_TX .. 135 PMTCT_ART .. 138 TB_ART .. 140 TX_CURR .. 142 146 TX_NEW .. 151 TX_RTT .. 154 TX_TB .. 157 VIRAL SUPPRESSION INDICATORS .. 160 TX_PVLS .. 161 HEALTH SYSTEMS INDICATORS .. 166 EMR_SITE .. 167 HRH_PRE .. 170 LAB_PTCQI .. 173 SC_ARVDISP .. 181 SC_CURR .. 185 OVERVIEW 5 UNCLASSIFIED HOST COUNTRY INDICATORS .. 188 DIAGNOSED_NAT .. 189 TX_CURR_NAT .. 191 VL_SUPPRESSION_NAT.

6 193 PMTCT_STAT_NAT .. 195 PMTCT_ART_NAT .. 197 VMMC_CIRC_NAT .. 198 VMMC_TOTALCIRC_NAT .. 199 HRH_STAFF_NAT .. 200 KP_MAT_NAT .. 202 monitoring SPECIAL INITIATIVES .. 203 DREAMS .. 204 Faith and Community Initiative .. 207 MenStar .. 210 Key Populations Investment Fund (KPIF) .. 211 Cervical Cancer Screening and Treatment .. 212 213 Appendix A: Key Populations Classification Document .. 214 Appendix B: Calculated Indicators Reference Table .. 215 Appendix C: DQA of National and Partner HIV Treatment and Patient monitoring Systems .. 225 Appendix D: Site and SNU Attributes and Epidemiologic Estimates.

7 235 Appendix E: Illustrative eligible services for Active OVC beneficiaries (children and caregivers) .. 237 Appendix F: Global OVC Graduation Benchmarks Matrix .. 240 Appendix G: HRH Inventory .. 242 Appendix H: monitoring Mortality Among PLHIV .. 244 Appendix I: Proposed HIV-Specific Short Cause of Death List .. 246 Appendix J: Visual Representation of TX_CURR, TX_ML, TX_NEW, and TX_RTT .. 247 Tables & Figures Figure 1: PEPFAR monitoring : Getting from Process to Impact .. 9 Figure 2: Patient-Centered monitoring in PEPFAR .. 10 Figure 3: Potential treatment client loss in one PEPFAR program from 2018-2019.

8 11 Figure 4: Indicator Reporting frequency and the PEPFAR fiscal year .. 12 Table 1: Evolution of PEPFAR Finer Age Bands for Results Reporting .. 15 Table 2: Host Country indicators by Reporting level, targets, and results .. 16 Figure 5. MER data flow from the site to country level .. 17 Figure 6. MER data entry and review process .. 18 Figure 7. MER result and target review favorites in DATIM .. 19 Figure 8. Naming convention for MER result and target review favorites in DATIM .. 19 Figure 9: Auto-Population of HTS_TST from Associated Indicators .. 20 Figure 10: Calculated Indicator examples.

9 23 Table 3: Indicator Summary Table .. 27 Table 4: Frequency of Reporting Table .. 30 Figure 11: PEPFAR MER Indicators Infographic .. 31 6 UNCLASSIFIED Abbreviations ART antiretroviral therapy ARV antiretroviral BF breastfeeding CBS case-based surveillance COD cause of death COP PEPFAR Country Operational Plan CQI continuous quality improvement CRVS civil registration and vital statistics CXCA cervical cancer DATIM Data for Accountability, Transparency, and Impact DQA data quality assessment DREAMS Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe DSD direct service delivery EID early infant diagnosis EMR electronic medical record FBO faith-based organization FCI Faith and Community Initiative FSW female sex worker FY fiscal year GAM UNAIDS Global AIDS monitoring GBV gender-based violence HCW health care worker HEI HIV-exposed infant HIVST HIV self-testing HRH human resources for health HTS HIV testing services IIT interruption in treatment IM implementing mechanism IP implementing partner L&D labor and delivery LTFU lost to follow-up KP key populations KPIF Key Populations Investment Fund MAT

10 Medication-assisted treatment MER monitoring , evaluation , and Reporting indicators MMD multi-month dispensing MOH Ministry of Health MSM men who have sex with men OVC orphans and vulnerable children OVERVIEW 7 UNCLASSIFIED PEP post-exposure prophylaxis PEPFAR United States President s Emergency Plan for AIDS Relief PHIA Public Health Impact Assessment PITC provider-initiated testing and counseling PLHIV people living with HIV PMTCT prevention of mother-to-child transmission POART PEPFAR Oversight and Accountability Response Team POCT point-of-care testing PP priority populations PrEP pre-exposure prophylaxis PT